[Federal Register Volume 83, Number 155 (Friday, August 10, 2018)]
[Notices]
[Page 39742]
[FR Doc No: 2018-17198]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings

    Take notice that the Commission has received the following Natural
Gas Pipeline Rate and Refund Report filings:

Filings Instituting Proceedings

    Docket Number: PR18-71-000.
    Applicants: Southern California Gas Company.
    Description: Tariff filing per 284.123(b),(e)+(g): OSHD Rate
Revision Filing--July 2018 to be effective 7/30/2018.
    Filed Date: 7/30/18.
    Accession Number:<PHONE_NUMBER>21.
    Comments Due: 5 p.m. ET 8/20/18.
    284.123(g) Protests Due: 5 p.m. ET 9/28/18.

    Docket Number: PR18-72-000.
    Applicants: Agua Blanca, LLC.
    Description: Tariff filing per 284.123(b),(e)/: Baseline refiled to
be effective 7/1/2018.
    Filed Date: 7/31/18.
    Accession Number:<PHONE_NUMBER>87.
    Comments/Protests Due: 5 p.m. ET 8/21/18.

    Docket Number: PR18-73-000.
    Applicants: Liberty Utilities (Midstates Natural Gas) Corp.
    Description: Tariff filing per 284.123(b),(e)/: Application for
Approval of Revised Statement of Rates to be effective 7/1/2018.
    Filed Date: 8/2/18.
    Accession Number:<PHONE_NUMBER>47.
    Comments/Protests Due: 5 p.m. ET 8/23/18.

    Docket Number: PR18-74-000.
    Applicants: Columbia Gas of Ohio, Inc.
    Description: Tariff filing per 284.123(b),(e)/: COH change Terms
and Conditions effective 9-1-2018.
    Filed Date: 8/2/18.
    Accession Number:<PHONE_NUMBER>81.
    Comments/Protests Due: 5 p.m. ET 8/23/18.

    Docket Numbers: RP18-1038-000.
    Applicants: Northern Border Pipeline Company.
    Description: Sec.  4(d) Rate Filing: Best Bid in GT&C 6.26.4 and
6.37.3 to be effective 9/1/2018.
    Filed Date: 8/1/18.
    Accession Number: 20180801-5156.
    Comments Due: 5 p.m. ET 8/13/18.

    Docket Numbers: RP18-789-002.
    Applicants: Cheniere Corpus Christi Pipeline, LP.
    Description: Compliance filing Baseline Compliance Filing (Metadata
Update)--RP18-789-000 to be effective 6/1/2018.
    Filed Date: 8/1/18.
    Accession Number: 20180801-5164.
    Comments Due: 5 p.m. ET 8/13/18.

    Docket Numbers: RP18-1039-000.
    Applicants: Texas Eastern Transmission, LP.
    Description: Sec.  4(d) Rate Filing: Negotiated Rate--Eco-Energy--
8952449 to be effective 8/2/2018.
    Filed Date: 8/2/18.
    Accession Number: 20180802-5023.
    Comments Due: 5 p.m. ET 8/14/18.

    Docket Numbers: RP18-1040-000.
    Applicants: Equitrans, L.P.
    Description: Sec.  4(d) Rate Filing: Negotiated Capacity Release
Agreements--8/3/2018 to be effective 8/3/2018.
    Filed Date: 8/2/18.
    Accession Number: 20180802-5113.
    Comments Due: 5 p.m. ET 8/14/18.

    Docket Numbers: RP18-1041-000.
    Applicants: Great Lakes Gas Transmission Limited Par.
    Description: Great Lakes Gas Transmission Limited Partnership Semi-
Annual Transporter's Use Report.
    Filed Date: 7/31/18.
    Accession Number: 20180731-5237.
    Comments Due: 5 p.m. ET 8/13/18.

    Docket Numbers: RP18-1042-000.
    Applicants: MoGas Pipeline LLC.
    Description: Penalty Revenue Crediting Report of MoGas Pipeline
LLC.
    Filed Date: 7/31/18.
    Accession Number: 20180731-5238.
    Comments Due: 5 p.m. ET 8/13/18.

    Docket Numbers: RP18-1043-000.
    Applicants: UGI Storage Company.
    Description: Operational Purchases and Sales Report of UGI Storage
Company.
    Filed Date: 8/1/18.
    Accession Number: 20180801-5211.
    Comments Due: 5 p.m. ET 8/13/18.

    Docket Numbers: RP18-1044-000.
    Applicants: ARP Mountaineer Production, LLC, Summit Natural
Resources, LLC.
    Description: Joint Petition for Temporary Waiver of Capacity
Release Regulations of ARP Mountaineer Production, LLC, et al. under
RP18-1044.
    Filed Date: 8/2/18.
    Accession Number: 20180802-5138.
    Comments Due: 5 p.m. ET 8/9/18.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: August 6, 2018.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2018-17198 Filed 8-9-18; 8:45 am]
 BILLING CODE 6717-01-P


[Federal Register: August 3, 2009 (Volume 74, Number 147)]
[Notices]
[Page 38480]
[DOCID:fr03au09-109]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Railroad Administration

Petition for Waiver of Compliance

    In accordance with part 211 of Title 49 Code of Federal Regulations
(CFR), notice is hereby given that the Federal Railroad Administration
(FRA) has received a request for a waiver of compliance from certain
requirements of its safety standards. The individual petition is
described below, including the party seeking relief, the regulatory
provisions involved, the nature of the relief being requested, and the
petitioner's arguments in favor of relief.

Canadian National Railway Company

(Waiver Petition Docket Number FRA-2009-0075)

    The Canadian National Railway Company (CN), the United
Transportation Union (UTU), and the Brotherhood of Locomotive Engineers
and Trainmen (BLET) jointly petitioned to establish a pilot project
under 49 U.S.C. 21108 providing for an alternative means of measuring
the monthly cycle under which employees' on-duty hours are capped at
276 hours per month. The pilot project would be made possible by a
partial waiver of 49 U.S.C. 21103(a)(1), permitting the cap on total
service for certain train employees to be computed on other than a
calendar month basis. The parties propose to divide the affected
employees into two groups, one of which would measure their on-duty
time from the first day of each month to the last day of the same
month. For the other group, the measurement would be made from the
fifteenth (15th) day of the month until the fourteenth (14th) day of
the following month. The parties aver that this approach will be as
effective as the statutory pattern in preventing fatigue while ensuring
that rested employees will be available throughout each calendar month.
The entire joint CN, UTU and BLE petition may be viewed at http://
www.regulations.gov under the docket number listed above.
    Interested parties are invited to participate in these proceedings
by submitting written views, data, or comments. FRA does not anticipate
scheduling a public hearing in connection with these proceedings, since
the facts do not appear to warrant a hearing. If any interested party
desires an opportunity for oral comment, they should notify FRA, in
writing, before the end of the comment period and specify the basis for
their request.
    All communications concerning these proceedings should identify the
appropriate docket number (Docket Number FRA-2009-0075) and may be
submitted by any of the following methods:
     Web site: http://www.regulations.gov. Follow the online
instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: Docket Operations Facility, U.S. Department of
Transportation, 1200 New Jersey Avenue, SE., W12-140, Washington, DC
20590.
     Hand Delivery: 1200 New Jersey Avenue, SE., Room W12-140,
Washington, DC 20590, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.
    Communications received within 20 days of the date of this notice
will be considered by FRA before final action is taken. Comments
received after that date will be considered as far as practicable. All
written communications concerning these proceedings are available for
examination during regular business hours (9 a.m.-5 p.m.) at the above
facility. All documents in the public docket are also available for
inspection and copying on the Internet at the docket facility's Web
site at http://www.regulations.gov.
    Anyone is able to search the electronic form of any written
communications and comments received into any of our dockets by the
name of the individual submitting the comment (or signing the comment,
if submitted on behalf of an association, business, labor union, etc.).
You may review DOT's complete Privacy Act Statement in the Federal
Register published on April 11, 2000 (Volume 65, Number 70; Pages
19477-78).

    Issued in Washington, DC, on July 28, 2009.
Grady C. Cothen, Jr.,
Deputy Associate Administrator for Safety Standards and Program
Development.
[FR Doc. E9-18443 Filed 7-31-09; 8:45 am]

BILLING CODE 4910-06-P


[Federal Register Volume 86, Number 156 (Tuesday, August 17, 2021)]
[Notices]
[Page 45979]
[FR Doc No: 2021-17631]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings

    Take notice that the Commission has received the following Natural
Gas Pipeline Rate and Refund Report filings:

Filings Instituting Proceedings

    Docket Number: PR21-59-000.
    Applicants: Arcadia Gas Storage, LLC.
    Description: Submits tariff filing per 284.123(b),(e)/: MBR
Authority Informational Notice, Compliance Dkt. Nos. PR09-15-000, PR16-
9-000 to be effective N/A.
    Filed Date: 8/10/2021.
    Accession Number: 20210810-5033.
    Comments/Protests Due: 5 p.m. ET 8/31/21.

    Docket Numbers: RP21-1023-000.
    Applicants: Pine Prairie Energy Center, LLC.
    Description: Compliance filing: Informational Filing Re MBR
Authority, Compliance Dkt. Nos. CP04-379 & CP11--to be effective N/A.
    Filed Date: 8/10/21.
    Accession Number: 20210810-5008.
    Comment Date: 5 p.m. ET 8/23/21.

    Docket Numbers: RP21-1024-000.
    Applicants: SG Resources Mississippi, L.L.C.
    Description: Compliance filing: Informational Filing Re MBR
Authority, Compliance Dkt. No. CP02-229 to be effective N/A.
    Filed Date: 8/10/21.
    Accession Number: 20210810-5009.
    Comment Date: 5 p.m. ET 8/23/21.

    Docket Numbers: RP21-1025-000.
    Applicants: Cadeville Gas Storage LLC.
    Description: Compliance filing: MBR Authority Informational Notice,
Compliance Dkt. No. CP10-16-000 to be effective N/A.
    Filed Date: 8/10/21.
    Accession Number: 20210810-5035.
    Comment Date: 5 p.m. ET 8/23/21.

    Docket Numbers: RP21-1026-000.
    Applicants: Monroe Gas Storage Company, LLC.
    Description: Compliance filing: MBR Authority Info Notice,
Compliance Dkt. Nos. CP07-406/407/408-000, RP16-591-000 to be effective
N/A.
    Filed Date: 8/10/21.
    Accession Number: 20210810-5036.
    Comment Date: 5 p.m. ET 8/23/21.

    Docket Numbers: RP21-1027-000.
    Applicants: Perryville Gas Storage LLC.
    Description: Compliance filing: MBR Authority Informational Notice,
Compliance Dkt. Nos. CP09-418-000, CP11-159-000 to be effective N/A.
    Filed Date: 8/10/21.
    Accession Number: 20210810-5037.
    Comment Date: 5 p.m. ET 8/23/21.

    Docket Numbers: RP21-1028-000.
    Applicants: Southwest Gas Storage Company.
    Description: Sec.  4(d) Rate Filing: Add Creditworthiness and Misc
Housekeeping to be effective 9/10/2021.
    Filed Date: 8/10/21.
    Accession Number: 20210810-5073.
    Comment Date: 5 p.m. ET 8/23/21.

    Docket Numbers: RP21-1029-000.
    Applicants: Southeast Supply Header, LLC.
    Description: Sec.  4(d) Rate Filing: FOSAs--Signature Block
Modifications to be effective 9/10/2021.
    Filed Date: 8/10/21.
    Accession Number: 20210810-5089.
    Comment Date: 5 p.m. ET 8/23/21.

    The filings are accessible in the Commission's eLibrary system
(https://elibrary.ferc.gov/idmws/search/fercgensearch.asp) by querying
the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: August 11, 2021.
Debbie-Anne A. Reese,
Deputy Secretary.
[FR Doc. 2021-17631 Filed 8-16-21; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register: September 18, 2006 (Volume 71, Number 180)]
[Notices]
[Page 54633]
[DOCID:fr18se06-39]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP06-440-000]

Columbia Gas Transmission Corporation; Notice of Application

September 8, 2006.
    Take notice that on August 31, 2006, Columbia Gas Transmission
Corporation (Columbia), 1700 MacCorkle Avenue, SE., Charleston, WV
25314, filed in Docket No. CP06-440-000 an application pursuant to
section 7(c) of the Natural Gas Act (NGA) for authorization to: (1)
Reclassify Clendenin 6 compressor unit from standby service to
base load status and increase its certificated horsepower from 2,700 to
3,550 hp; and (2) increase the certificated horsepower of the Clendenin
Compressor Station located in Kanawha County, West Virginia from 19,000
hp to 22,550 hp. This filing is available for review at the Commission
in the Public Reference Room or may be viewed on the Web at http://www.ferc.gov
 using the ``eLibrary'' link. Enter the docket number

excluding the last three digits in the docket number field to access
the document. For assistance, contact FERC at
<EMAIL_ADDRESS>or call toll-free,<PHONE_NUMBER> or TYY,

(202) 502-8659.
    Any questions regarding this application should be directed to
counsel for Columbia, Fredric J. George, Lead Counsel, Columbia Gas
Transmission Corporation, P.O. Box 1273, Charleston, West Virginia
25325-1273; telephone<PHONE_NUMBER>, fax<PHONE_NUMBER>.
    There are two ways to become involved in the Commission's review of
this project. First, any person wishing to obtain legal status by
becoming a party to the proceedings for this project should, on or
before the comment date, file with the Federal Energy Regulatory
Commission, 888 First Street, NE., Washington, DC 20426, a motion to
intervene in accordance with the requirements of the Commission's Rules
of Practice and Procedure (18 CFR 385.214 or 385.211) and the
Regulations under the NGA (18 CFR 157.10). A person obtaining party
status will be placed on the service list maintained by the Secretary
of the Commission and will receive copies of all documents filed by the
applicant and by all other parties. A party must submit 14 copies of
filings made with the Commission and must mail a copy to the applicant
and to every other party in the proceeding. Only parties to the
proceeding can ask for court review of Commission orders in the
proceeding.
    However, a person does not have to intervene in order to have
comments considered. The second way to participate is by filing with
the Secretary of the Commission, as soon as possible, an original and
two copies of comments in support of or in opposition to this project.
The Commission will consider these comments in determining the
appropriate action to be taken, but the filing of a comment alone will
not serve to make the filer a party to the proceeding. The Commission's
rules require that persons filing comments in opposition to the project
provide copies of their protests only to the party or parties directly
involved in the protest.
    The Commission strongly encourages electronic filings of comments,
protests, and interventions via the internet in lieu of paper. See 18
CFR 385.2001(a)(1)(iii) and the instructions on the Commission's Web
site (http://www.ferc.gov) under the ``e-Filing'' link.

    Comment Date: September 29, 2006.

Magalie R. Salas,
Secretary.
[FR Doc. E6-15378 Filed 9-15-06; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 88, Number 64 (Tuesday, April 4, 2023)]
[Notices]
[Page 20018]
[FR Doc No: 2023-06992]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Railroad Administration

[Docket Number FRA-2017-0126]

Petition for Extension of Waiver of Compliance

    Under part 211 of title 49 Code of Federal Regulations (CFR), this
document provides the public notice that by letter received on March
13, 2023, the Denton County Transportation Authority (DCTA) petitioned
the Federal Railroad Administration (FRA) for an extension of a waiver
of compliance from certain provisions of the Federal railroad safety
regulations contained at 49 CFR part 240 (Qualification and
Certification of Locomotive Engineers) and part 242 (Qualification and
Certification of Conductors). The relevant docket number is FRA-2017-
0126.
    Specifically, DCTA requests continued relief as part of its
participation in FRA's Confidential Close Call Reporting System
(C\3\RS) Program. DCTA seeks to shield reporting employees and the
railroad from mandatory punitive sanctions that would otherwise arise
as provided in Sec. Sec.  240.117(e)(1)-(4); 240.305(a)(l)-(4) and
(a)(6); 240.307; 242.403(b), (c), (e)(l)-(4), (e)(6)-(11), (f)(l)-(2);
and 242.407. The C\3\RS Program encourages certified operating crew
members to report close calls and protects the employees and the
railroad from discipline or sanctions arising from the incidents
reported per the C\3\RS Implementing Memorandum of Understanding.
    A copy of the petition, as well as any written communications
concerning the petition, is available for review online at
www.regulations.gov.
    Interested parties are invited to participate in these proceedings
by submitting written views, data, or comments. FRA does not anticipate
scheduling a public hearing in connection with these proceedings since
the facts do not appear to warrant a hearing. If any interested parties
desire an opportunity for oral comment and a public hearing, they
should notify FRA, in writing, before the end of the comment period and
specify the basis for their request.
    All communications concerning these proceedings should identify the
appropriate docket number and may be submitted at http://www.regulations.gov. Follow the online instructions for submitting
comments.
    Communications received by June 5, 2023 will be considered by FRA
before final action is taken. Comments received after that date will be
considered if practicable.
    Anyone can search the electronic form of any written communications
and comments received into any of our dockets by the name of the
individual submitting the comment (or signing the document, if
submitted on behalf of an association, business, labor union, etc.).
Under 5 U.S.C. 553(c), DOT solicits comments from the public to better
inform its processes. DOT posts these comments, without edit, including
any personal information the commenter provides, to
www.regulations.gov, as described in the system of records notice (DOT/
ALL-14 FDMS), which can be reviewed at https://www.transportation.gov/privacy. See also https://www.regulations.gov/privacy-notice for the
privacy notice of regulations.gov.

    Issued in Washington, DC.
John Karl Alexy,
Associate Administrator for Railroad Safety, Chief Safety Officer.
[FR Doc. 2023-06992 Filed 4-3-23; 8:45 am]
BILLING CODE 4910-06-P


[Federal Register Volume 77, Number 155 (Friday, August 10, 2012)]
[Notices]
[Pages 47899-47902]
[FR Doc No: 2012-19611]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-67598; File No. SR-EDGX-2012-33]

Self-Regulatory Organizations; EDGX Exchange, Inc.; Notice of
Filing of Proposed Rule Change to Amend EDGX Rule 11.5(c) to add the
Edge Market Close \SM\ Order

August 6, 2012.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(the ``Act'') \1\ and Rule 19b-4 thereunder,\2\

notice is hereby given that, on July 27, 2012, the EDGX Exchange, Inc.
(the ``Exchange'' or ``EDGX'') filed with the Securities and Exchange
Commission (the ``Commission'') the proposed rule change as described
in Items I and II below, which Items have been prepared by the self-
regulatory organization. The Commission is publishing this notice to
solicit comments on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to amend Rule 11.5(c) to add a new order
type, the Edge Market CloseSM (``EMC'') Order, to the rule.
The text of the proposed rule changes is available on the Exchange's
Web site at www.directedge.com, at the Exchange's principal office and
at the Public Reference Room of the Commission.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the Exchange included statements
concerning the purpose of, and basis for, the proposed rule changes and
discussed any comments it received on the proposed rule changes. The
text of these statements may be examined at the places specified in
Item IV below. The self-regulatory organization has prepared summaries,
set forth in Sections A, B and C below, of the most significant aspects
of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange is proposing to amend Rule 11.5(c) to add new
subparagraph (15), which would describe a new order type, the EMC
Order. An EMC Order would be defined as an order to buy or sell on the
Exchange a security that is listed on the New York Stock Exchange LLC
(the ``NYSE'') or The NASDAQ Stock Market LLC (``NASDAQ'') (each, a
``Listing Market'') at the official closing price of such security
published by the corresponding Listing Market.\3\ Users \4\ would be
able to enter, cancel and cancel/replace EMC Orders from prior to the
Pre-Opening Session \5\ on trade date until five (5) minutes prior to
the ``cut-off time'' for the entry of Market At-the-Close Orders on the
NYSE and Market-on-Close Orders on NASDAQ (in each case, the ``EMC Cut-
Off Time'').\6\ All EMC Orders on the EDGX Book \7\ at the EMC Cut-Off
Time would be locked-in either for execution on the Exchange or for
routing to the applicable Listing Market (to the extent not otherwise
matched with a contra-side EMC Order), as described below. Users would
not be able to cancel or cancel/replace any EMC Order after the EMC
Cut-Off Time, and the Exchange would reject back to the User any EMC
Order received after the EMC Cut-Off Time. During the time between the
EMC Cut-Off Time and the NYSE Cut-Off Time or the NASDAQ Cut-Off time,
as the case may be, the Exchange would calculate, for each security for
which EMC Orders were entered, the maximum number of shares underlying
such EMC Orders that can be matched, or paired off. Priority on the
EDGX Book for EMC Orders would be based strictly on time of entry. EMC
Orders would be eligible for partial execution on the Exchange. The
unmatched portion of any EMC Orders that could not be paired off on the
Exchange pursuant to this process would then be routed as Market At-
the-Close Orders to the closing process of the NYSE for NYSE-listed
stocks, or as Market-on-Close Orders to the closing process of NASDAQ
for NASDAQ-listed stocks. If there was no contra-side EMC Order on the
Exchange to match against a particular EMC Order, then such EMC Order
would be routed to the closing process of the applicable Listing Market
as described above. The execution price of an EMC Order executed on the
Exchange would be the official closing price \8\ published by the NYSE
for EMC Orders in NYSE-listed stocks, or by NASDAQ for EMC Orders in
NASDAQ-listed stocks, and Users would be charged fees, if any, for such
executions according to the Exchange's published fee schedule. The
execution prices of the unmatched portion of any EMC Orders that were
routed to the applicable Listing Market for execution in such Listing
Market's closing auction would also be the official closing price
published by such Listing Market, and the Exchange would pass through
to the Member any fees charged by the Listing Market for the execution
of orders in its respective closing process.
---------------------------------------------------------------------------

    \3\ In the event that a particular security were listed on both
the NYSE and NASDAQ, the Exchange would select one of such exchanges
for purposes of ascertaining the official closing price for the
execution of EMC Orders in such security, based on the exchange with
the greater market share in the security measured over the previous
three (3) calendar months. The Exchange would disclose on its Web
site such selection prospectively in advance of offering the EMC
Order in such security.
    \4\ As defined in EDGX Rule 1.5(ee).
    \5\ As defined in EDGX Rule 1.5(s).
    \6\ Currently, the NYSE designates the cut-off time for the
entry of Market At-the-Close Orders as 3:45 p.m. Eastern Time (the
``NYSE Cut-off Time''). See NYSE Rule 123C. NASDAQ in turn,
designates the ``end of the order entry period'' as 3:50 p.m. (the
``NASDAQ Cut-Off Time''). See NASDAQ Rule 4754. Thus, the EMC Cut-
Off Times would be 3:40 p.m. for EMC Orders in NYSE-listed stocks,
and 3:45 p.m. for EMC Orders in NASDAQ-listed stocks.
    \7\ As defined in EDGX Rule 1.5(d).
    \8\ For example, NYSE Rule 900(e) defines ``closing price'' as
``the price established by the last `regular way' sale in a security
prior to the official closing of the 9:30 a.m. to 4:00 p.m. trading
session, as determined by the Exchange.'' Further, while the term
``NASDAQ Official Closing Price'' is not specifically defined in
NASDAQ's rules, it is referenced in NASDAQ IM-5505(b) and NASDAQ
Rules 4753 (halt and imbalance crosses) and 4754 (closing cross).
---------------------------------------------------------------------------

    The following examples illustrate how the EMC Order would work. In
each case, assume that XYZ stock is listed on the NYSE; therefore, the
EMC Cut-Off Time would be 3:40 p.m.

    Example 1: Member A enters an EMC Order to buy 500 shares of XYZ
at 2:00 p.m. Member B enters an EMC Order to sell 300 shares of XYZ
at 2:30 p.m. At or shortly after 3:40 p.m. but prior to the NYSE
Cut-Off Time of 3:45 p.m., the Exchange would pair off Member B's
EMC Order to sell 300 shares with 300 shares of Member A's EMC Order
to buy 500 shares, leaving a remainder of 200 shares to buy. Before
3:45 p.m., the remaining 200 shares of Member A's order would be
routed to the NYSE via EDGX's routing broker-dealer, Direct Edge ECN
LLC d/b/a DE Route, as a Market At-the-Close Order.
    After 4:00 p.m., the Exchange would execute Member A's and
Member B's EMC Orders, for 300 shares each, at the official closing
price for XYZ published by the NYSE and report such execution to the
responsible Securities Information Processor. The Exchange would
also report back to Member A an execution at the official closing
price of the remaining 200 shares in the NYSE's closing auction, and
pass through to Member A the fees charged by the NYSE for executions
of Market At-the-Close Orders in its closing auction.
    Example 2: Assume the same facts as above, except now Member C
enters an EMC Order to buy 1000 shares of XYZ at 3:40:02 p.m. The
Exchange would reject the order back to Member C because it would
have been submitted after the EMC Cut-Off Time of 3:40 p.m.
    Example 3: Assume the same facts as above, except now Member D
enters an EMC Order to buy 300 shares of XYZ at 3:15 p.m., and at
3:20 p.m. Member A cancels its EMC Order to buy 500 shares and
replaces it with an EMC Order to buy 700 shares. Following the EMC
Cut-Off Time at 3:40 p.m., the Exchange would pair off Member D's
EMC Order to buy 300 shares with Member B's EMC Order to sell 300
shares, as Member A would have lost its time priority on the Book
when it cancelled and replaced its original order with greater size.
Member A's order would then be routed via DE Route to the NYSE as a
Market At-the-Close Order in accordance with NYSE rules.

    The Exchange is proposing the EMC Order in order to increase the
level of

competition for orders seeking execution at the official closing
price.\9\ No other national securities exchange has offered its members
the ability to obtain a closing price execution away from the NYSE and
NASDAQ; as a result, the Exchange believes that the fees that the NYSE
and NASDAQ charge for executions of Market At-the-Close Orders and
Market-on-Close Orders, respectively, are not being sufficiently
challenged by competitive forces. While robust competition between and
among national securities exchanges and alternative market centers for
intraday equities order flow has resulted in a steady decrease in
trading fees over the previous decade, the fees charged by the NYSE and
NASDAQ for closing price executions have actually increased over the
past six years.
---------------------------------------------------------------------------

    \9\ If and to the extent that the Exchange charges any fees for
the execution of EMC Orders, it will file such fees with the
Commission and post them on its Web site prior to implementation of
the EMC Order.
---------------------------------------------------------------------------

    For example, from August 2006 through July 2009, excluding any
tiered discounts offered by NASDAQ, NASDAQ charged $0.0005 per side for
closing price executions,\10\ which increased to $0.0007 per side in
2009 \11\ and to $0.0010 per side in 2010 \12\--approximately doubling
the rate in 3 years. Thus, currently the ``cost of match'' \13\ for
closing price executions on NASDAQ is approximately $0.0020, or ``20
mils''.\14\ Similarly, excluding any tiered discounts offered by the
NYSE, the NYSE increased its rate from $0.0005 per side to $0.0007 per
side in August 2009,\15\ then to $0.00085 per side from September 2010
\16\ to March 2012, when it was increased to $0.00095 per side,\17\
nearly doubling its rates in approximately three years. Thus, the cost
of match for closing price executions on the NYSE is approximately
$0.0019, or ``19 mils''.\18\
---------------------------------------------------------------------------

    \10\ See Securities Exchange Act Release No. 60323 (July 16,
2009), 74 FR 36543 (July 23, 2009) (SR-NASDAQ-2009-67) (citing to
the proposition that NASDAQ did not modify its fee for MOC orders
since it began to operate as a national securities exchange in
2006).
    \11\ Id.
    \12\ See Securities Exchange Act Release No. 62592 (July 29,
2010), 75 FR 47053 (August 4, 2010) (SR-NASDAQ-2010-95).
    \13\ For purposes of this rule filing, the ``cost of match''
refers to the total or net cost of a single execution to both sides
of the transaction. For closing price executions on NASDAQ and the
NYSE, for example, it is currently measured by the explicit fee
charged to both sides of the cross (although under certain narrow
circumstances, on one or both sides, they are subject to reduction,
as described infra at footnotes 14 and 18). For most exchanges,
however, the ``cost of match'' for intraday matches or executions is
generally calculated by netting rebate credits against take or
removal fees.
    \14\ The rate per share can be reduced to $0.0001 only in the
case of internalized shares (meaning, those shares executed in the
NASDAQ Closing Cross that execute against other ``on close'' orders
submitted by the same Market Participant Identifier (``MPID'')) of
MPIDs that execute more than 100 million Market-on-Close or Limit-
on-Close Orders in the NASDAQ Closing Cross per month, and that add
liquidity meeting the thresholds equivalent to NASDAQ's $0.00295
pricing tier.
    \15\ See Securities Exchange Act Release No. 60436 (August 5,
2009), 74 FR 40252 (August 11, 2009) (SR-NYSE-2009-77).
    \16\ See Securities Exchange Act Release No. 62826 (September 1,
2010), 75 FR 54928 (September 9, 2010) (SR-NYSE-2010-63).
    \17\ See Securities Exchange Act Release No. 66600 (March 20,
2012) [sic], 77 FR 16298 (March 20, 2012) (SR-NYSE-2012-07).
    \18\ The rate per share can be reduced to $0.00055 for market
participants whose average daily volume of ``on close'' orders is 14
million shares or more.
---------------------------------------------------------------------------

    Relative to intraday matches or executions the fees charged by the
NYSE and NASDAQ for closing price executions are significantly more
expensive. For example, large order flow providers that reach certain
of NASDAQ's top tiers have a typical cost of match that varies from
$0.00005 to $0.0005 (or ``1/2 a mil'' to ``5 mils'').\19\ Moreover, a
typical cost of match for market participants that are not Designated
Market Makers (``DMMs'') or Supplemental Liquidity Providers (``SLPs'')
on the NYSE is approximately $0.0008 (or ``8 mils'').\20\
---------------------------------------------------------------------------

    \19\ For example, NASDAQ's cost of match at two of its top tiers
can be approximated by subtracting the rebate credit (0.00295 or
0.0025) from the take or removal fee (0.0030) to equal 0.00005 or
0.0005/share, respectively. See http://www.nasdaqtrader.com/Trader.aspx?id=PriceListTrading2.
    \20\ Non-DMM and non-SLP liquidity providers earn a rebate of
0.0015 per share. Non-floor based liquidity removers are charged
0.0023 per share. Thus, the approximate cost of match on the NYSE
(for non-DMM and non-SLPs) is 0.0008 per share. See http://usequities.nyx.com/markets/nyse-equities/trading-fees.
---------------------------------------------------------------------------

    The Exchange has designed the EMC Order to provide an alternative
means to obtain a closing price execution, without any impact on the
price discovery function of the NYSE's and NASDAQ's respective closing
processes. The existence of an alternative venue to obtain closing
price executions introduces competition, and, consequently, a potential
decrease in the fees charged to market participants for such
executions.\21\ Moreover, the EMC Order would not impact the price
discovery function of the NYSE's and NASDAQ's respective closing
processes by replicating only market-on-close type orders, as opposed
to limit-on-close orders, and the Exchange would only execute those EMC
Orders that naturally paired off and effectively cancelled each other
out. Any unmatched EMC Orders would be routed to the applicable Listing
Market for execution in that Listing Market's closing process.
---------------------------------------------------------------------------

    \21\ It is the Exchange's intention, upon the Commission
approval of the EMC Order, to offer executions of EMC Orders, to the
extent matched on the Exchange, at zero cost for at least some
period of time. It is further the Exchange's intention that, if and
when it determines to charge a fee for the execution on the Exchange
of an EMC Order, such fee would be less than the fee charged by the
applicable Listing Market.
---------------------------------------------------------------------------

2. Statutory Basis
    The Exchange believes that the proposed rule change is consistent
with Section 6(b) of the Act \22\ and furthers the objectives of
Section 6(b)(5) of the Act,\23\ in that it is designed to prevent
fraudulent and manipulative acts and practices, to promote just and
equitable principles of trade, to foster cooperation and coordination
with persons engaged in facilitating transactions in securities, and to
remove impediments to and perfect the mechanisms of a free and open
market and a national market system, and, in general, to protect
investors and the public interest.
---------------------------------------------------------------------------

    \22\ 15 U.S.C. 78f(b).
    \23\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

    In particular, the proposed rule change would remove impediments to
and perfect the mechanisms of a free and open market and a national
market system, and foster cooperation and coordination with persons
engaged in facilitating transactions in securities, by promoting
competition among national securities exchanges in the execution of
matching closing price orders without disrupting the price discovery
process of NYSE's and NASDAQ's respective closing processes. The EMC
Order would be neutral to price discovery, as it would only execute on
the Exchange against a matching contra-side EMC Order. Any imbalance
resulting from unmatched EMC Orders to the buy or sell side would be
routed to the applicable Listing Market for execution in their
respective closing processes. The proposed rule change would protect
investors and the public interest by encouraging the NYSE and NASDAQ to
compete for market orders in their closing processes.

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule changes will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    The Exchange has neither solicited nor received written comments on
the proposed rule changes.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Within 45 days of the date of publication of this notice in the
Federal Register or within such longer period (i) as the Commission may
designate up to 90 days of such date if it finds such longer period to
be appropriate and publishes its reasons for so finding or (ii) as to
which the self-regulatory organization consents, the Commission will:
    (A) By order approve or disapprove the proposed rule change, or
    (B) Institute proceedings to determine whether the proposed rule
change should be disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to<EMAIL_ADDRESS>Please include
File Number SR-EDGX-2012-33 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth M. Murphy,
Secretary, Securities and Exchange Commission, 100 F Street NE.,
Washington, DC 20549-1090.

All submissions should refer to File Number SR-EDGX-2012-33. This file
number should be included on the subject line if email is used. To help
the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for Web site viewing and
printing in the Commission's Public Reference Room, 100 F Street NE.,
Washington, DC 20549, on official business days between the hours of
10:00 a.m. and 3:00 p.m. Copies of the filing also will be available
for inspection and copying at the principal office of the Exchange. All
comments received will be posted without change; the Commission does
not edit personal identifying information from submissions. You should
submit only information that you wish to make available publicly. All
submissions should refer to File Number SR-EDGX-2012-33 and should be
submitted on or before August 31, 2012.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\24\
---------------------------------------------------------------------------

    \24\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Kevin M. O'Neill,
Deputy Secretary.
[FR Doc. 2012-19611 Filed 8-9-12; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 84, Number 53 (Tuesday, March 19, 2019)]
[Notices]
[Page 10065]
[FR Doc No: 2019-05062]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER19-1242-000]

Supplemental Notice That Initial Market-Based Rate Filing
Includes Request for Blanket Section 204 Authorization: Sage Solar III
LLC

    This is a supplemental notice in the above-referenced proceeding of
Sage Solar III LLC's application for market-based rate authority, with
an accompanying rate tariff, noting that such application includes a
request for blanket authorization, under 18 CFR part 34, of future
issuances of securities and assumptions of liability.
    Any person desiring to intervene or to protest should file with the
Federal Energy Regulatory Commission, 888 First Street NE, Washington,
DC 20426, in accordance with Rules 211 and 214 of the Commission's
Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone
filing a motion to intervene or protest must serve a copy of that
document on the Applicant.
    Notice is hereby given that the deadline for filing protests with
regard to the applicant's request for blanket authorization, under 18
CFR part 34, of future issuances of securities and assumptions of
liability, is April 1, 2019.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically should submit an original and
5 copies of the intervention or protest to the Federal Energy
Regulatory Commission, 888 First Street NE, Washington, DC 20426.
    The filings in the above-referenced proceeding are accessible in
the Commission's eLibrary system by clicking on the appropriate link in
the above list. They are also available for electronic review in the
Commission's Public Reference Room in Washington, DC. There is an
eSubscription link on the website that enables subscribers to receive
email notification when a document is added to a subscribed docket(s).
For assistance with any FERC Online service, please email
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For
TTY, call<PHONE_NUMBER>.

    Dated: March 12, 2019.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2019-05062 Filed 3-18-19; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 82, Number 44 (Wednesday, March 8, 2017)]
[Notices]
[Pages 13050-13056]
[FR Doc No: 2017-04524]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2016-0383]

Qualification of Drivers; Exemption Applications; Diabetes
Mellitus

AGENCY: Federal Motor Carrier Safety Administration (FMCSA).

ACTION: Notice of applications for exemptions; request for comments.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces receipt of applications from 41 individuals
for exemption from the prohibition against persons with insulin-treated
diabetes mellitus (ITDM) operating commercial motor vehicles (CMVs) in
interstate commerce. If granted, the exemptions would enable these
individuals with ITDM to operate CMVs in interstate commerce.

DATES: Comments must be received on or before April 7, 2017.

ADDRESSES: You may submit comments bearing the Federal Docket
Management System (FDMS) Docket No. FMCSA-2016-0383 using any of the
following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the on-line instructions for submitting
comments.
     Mail: Docket Management Facility; U.S. Department of
Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery: West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m.,
e.t., Monday through Friday, except Federal Holidays.
     Fax: 1-202-493-2251.
    Instructions: Each submission must include the Agency name and the
docket numbers for this notice. Note that all comments received will be
posted without change to http://www.regulations.gov, including any

personal information provided. Please see the Privacy Act heading below
for further information.
    Docket: For access to the docket to read background documents or
comments, go to http://www.regulations.gov at any time or Room W12-140
on the ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday,
except Federal holidays. The Federal Docket Management System (FDMS) is
available 24 hours each day, 365 days each year. If you want
acknowledgment that we received your comments, please include a self-
addressed, stamped envelope or postcard or print the acknowledgement
page that appears after submitting comments on-line.
    Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits
comments from the public to better inform its rulemaking process. DOT
posts these comments, without edit, including any personal information
the commenter provides, to www.regulations.gov, as described in the
system of records notice (DOT/ALL-14 FDMS), which can be reviewed at
www.dot.gov/privacy.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division,<PHONE_NUMBER><EMAIL_ADDRESS>FMCSA,
Department of Transportation, 1200 New Jersey Avenue SE., Room W64-113,
Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t.,
Monday through Friday, except Federal holidays.

SUPPLEMENTARY INFORMATION:

I. Background

    Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the Federal Motor Carrier Safety Regulations for a 2-year period
if it finds ``such exemption would likely achieve a level of safety
that is equivalent to or greater than the level that would be achieved
absent such exemption.'' The statute also allows the Agency to renew
exemptions at the end of the 2-year period. The 41 individuals listed
in this notice have recently requested such an exemption from the
diabetes prohibition in 49 CFR 391.41(b) (3), which applies to drivers
of CMVs in interstate commerce. Accordingly, the Agency will evaluate
the qualifications of each applicant to determine whether granting the
exemption will achieve the required level of safety mandated by
statute.

II. Qualifications of Applicants

Joseph A. Akers

    Mr. Akers, 24, has had ITDM since 2007. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Akers understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Akers meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he has stable
nonproliferative diabetic retinopathy. He holds an operator's license
from West Virginia.

Leslie R. Auger

    Mr. Auger, 58, has had ITDM since 2016. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Auger understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Auger meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Missouri.

Ta Canunpa W. Banks

    Mr. Banks, 32, has had ITDM since 2015. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Banks understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Banks meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he does not
have diabetic retinopathy. He holds an operator's license from South
Dakota.

Ralph E. Beard

    Mr. Beard, 53, has had ITDM since 2016. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Beard understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Beard meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he does not
have diabetic retinopathy. He holds a Class C CDL from Michigan.

Darrell W. Britnell

    Mr. Britnell, 50, has had ITDM since 2015. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Britnell understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Britnell meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class B CDL from North Carolina.

Paul M. Capeder

    Mr. Capeder, 56, has had ITDM since 2016. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Capeder understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV

safely. Mr. Capeder meets the requirements of the vision standard at 49
CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and
certified that he does not have diabetic retinopathy. He holds a Class
B CDL from Minnesota.

Robert D. Carnazzo

    Mr. Carnazzo, 47, has had ITDM since 2016. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Carnazzo understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Carnazzo meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class B CDL from Massachusetts.

Randall C. Coleman

    Mr. Coleman, 64, has had ITDM since 1998. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Coleman understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Coleman meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he has stable
nonproliferative and stable proliferative diabetic retinopathy. He
holds an operator's license from Washington.

Thomas K. Coleman

    Mr. Coleman, 24, has had ITDM since 2015. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Coleman understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Coleman meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he does not
have diabetic retinopathy. He holds an operator's license from North
Carolina.

Mark A. Cologne

    Mr. Cologne, 52, has had ITDM since 2016. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Cologne understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Cologne meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Louisiana.

Christopher J. Comstock

    Mr. Comstock, 28, has had ITDM since 2000. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Comstock understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Comstock meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Texas.

Alexander H. Cromartie

    Mr. Cromartie, 64, has had ITDM since 2012. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Cromartie understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Cromartie meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he has stable
nonproliferative diabetic retinopathy. He holds a Class A CDL from
Pennsylvania.

Michael R. Dark

    Mr. Dark, 36, has had ITDM since 2006. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Dark understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Dark meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2016 and certified that he does not have diabetic retinopathy. He
holds an operator's license from Texas.

Joseph P. Dellavolpe

    Mr. Dellavolpe, 67, has had ITDM since 2015. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Dellavolpe understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Dellavolpe meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he does not
have diabetic retinopathy. He holds an operator's license from New
Jersey.

Shea E. Durand

    Mr. Durand, 28, has had ITDM since 2001. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the

assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Durand understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Durand meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds an operator's license from New York.

David L. Farris

    Mr. Farris, 55, has had ITDM since 1990. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Farris understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Farris meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Kansas.

Donald D. Fown

    Mr. Fown, 58, has had ITDM since 2003. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Fown understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Fown meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined
him in 2016 and certified that he has stable nonproliferative diabetic
retinopathy. He holds a Class A CDL from Ohio.

Michael L. Gamache

    Mr. Gamache, 55, has had ITDM since 2014. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Gamache understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Gamache meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from New Hampshire.

David P. Glaeser

    Mr. Glaeser, 48, has had ITDM since 2014. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Glaeser understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Glaeser meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Colorado.

Donald J. Gray

    Mr. Gray, 58, has had ITDM since 2015. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Gray understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Gray meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2016 and certified that he does not have diabetic retinopathy. He
holds a Class B CDL from California.

James E. Guthrie, IV

    Mr. Guthrie, 22, has had ITDM since 2013. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Guthrie understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Guthrie meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Kentucky.

James F. Hamilton

    Mr. Hamilton, 60, has had ITDM since 2009. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Hamilton understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Hamilton meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds an operator's license from South Dakota.

Paul R. Hanson

    Mr. Hanson, 54, has had ITDM since 2016. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Hanson understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Hanson meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Minnesota.

Jaculyn E. Heck

    Ms. Heck, 51, has had ITDM since 1999. Her endocrinologist examined
her in 2016 and certified that she has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. Her
endocrinologist certifies that Ms. Heck understands diabetes management
and monitoring has stable control of her diabetes using insulin, and is
able to drive a CMV safely. Ms. Heck meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). Her ophthalmologist examined
her in 2016 and certified that she has stable nonproliferative diabetic
retinopathy. She holds an operator's license from Delaware.

Greg J. Isom

    Mr. Isom, 31, has had ITDM since 2001. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Isom understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Isom meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined
him in 2016 and certified that he has stable nonproliferative diabetic
retinopathy. He holds a Class A CDL from Georgia.

Mark J. Johnson

    Mr. Johnson, 63, has had ITDM since 2014. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Johnson understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Johnson meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Washington.

Tyson C. Johnson

    Mr. Johnson, 34, has had ITDM since 1994. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Johnson understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Johnson meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he has stable
nonproliferative diabetic retinopathy. He holds a Class B CDL from
Pennsylvania.

Darrell W. Luck

    Mr. Luck, 67, has had ITDM since 2015. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Luck understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Luck meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2016 and certified that he does not have diabetic retinopathy. He
holds a Class A CDL from North Carolina.

Gregory L. Markin

    Mr. Markin, 48, has had ITDM since 2014. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Markin understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Markin meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Wisconsin.

Patrick May

    Mr. May, 61, has had ITDM since 2014. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. May understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. May meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined
him in 2016 and certified that he does not have diabetic retinopathy.
He holds an operator's license from Maryland.

Elbert J. Means

    Mr. Means, 65, has had ITDM since 2013. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Means understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Means meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from South Carolina.

Peter R. Meyer

    Mr. Meyer, 54, has had ITDM since 2016. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Meyer understands

diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Meyer meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Washington.

Andrew R. Morris

    Mr. Morris, 24, has had ITDM since 2013. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Morris understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Morris meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Washington.

Timothy A. Parks, Jr.

    Mr. Parks, 24, has had ITDM since 2010. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Parks understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Parks meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Maryland.

Dennis Pitt

    Mr. Pitt, 54, has had ITDM since 2015. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Pitt understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Pitt meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2016 and certified that he does not have diabetic retinopathy. He
holds a Class B CDL from New York.

Antonio R. Ragin

    Mr. Ragin, 43, has had ITDM since 1997. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Ragin understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Ragin meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he has stable
nonproliferative diabetic retinopathy. He holds a Class A CDL from
Connecticut.

Matthew Reynolds

    Mr. Reynolds, 54, has had ITDM since 2012. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Reynolds understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Reynolds meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Pennsylvania.

Robert G. Smith

    Mr. Smith, 57, has had ITDM since 2015. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Smith understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Smith meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Massachusetts.

Patricia M. Spurgeon

    Ms. Spurgeon, 63, has had ITDM since 2014. Her endocrinologist
examined her in 2016 and certified that she has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
Her endocrinologist certifies that Ms. Spurgeon understands diabetes
management and monitoring has stable control of her diabetes using
insulin, and is able to drive a CMV safely. Ms. Spurgeon meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). Her
ophthalmologist examined her in 2016 and certified that she does not
have diabetic retinopathy. She holds a Class C CDL from New York.

Robert M. Sypolt

    Mr. Sypolt, 54, has had ITDM since 2013. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Sypolt understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Sypolt meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he has stable
nonproliferative diabetic retinopathy. He holds a Class A CDL from West
Virginia.

Brandon R. Wedding

    Mr. Wedding, 32, has had ITDM since 2016. His endocrinologist
examined him

in 2016 and certified that he has had no severe hypoglycemic reactions
resulting in loss of consciousness, requiring the assistance of another
person, or resulting in impaired cognitive function that occurred
without warning in the past 12 months and no recurrent (2 or more)
severe hypoglycemic episodes in the last 5 years. His endocrinologist
certifies that Mr. Wedding understands diabetes management and
monitoring, has stable control of his diabetes using insulin, and is
able to drive a CMV safely. Mr. Wedding meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2016 and certified that he does not have diabetic retinopathy. He
holds a Class A CDL from Oregon.

III. Request for Comments

    In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests
public comment from all interested persons on the exemption petitions
described in this notice. We will consider all comments received before
the close of business on the closing date indicated in the date section
of the notice.
    FMCSA notes that section 4129 of the Safe, Accountable, Flexible
and Efficient Transportation Equity Act: A Legacy for Users requires
the Secretary to revise its diabetes exemption program established on
September 3, 2003 (68 FR 52441).\1\ The revision must provide for
individual assessment of drivers with diabetes mellitus, and be
consistent with the criteria described in section 4018 of the
Transportation Equity Act for the 21st Century (49 U.S.C. 31305).
---------------------------------------------------------------------------

    \1\ Section 4129(a) refers to the 2003 notice as a ``final
rule.'' However, the 2003 notice did not issue a ``final rule'' but
did establish the procedures and standards for issuing exemptions
for drivers with ITDM.
---------------------------------------------------------------------------

    Section 4129 requires: (1) Elimination of the requirement for 3
years of experience operating CMVs while being treated with insulin;
and (2) establishment of a specified minimum period of insulin use to
demonstrate stable control of diabetes before being allowed to operate
a CMV.
    In response to section 4129, FMCSA made immediate revisions to the
diabetes exemption program established by the September 3, 2003 notice.
FMCSA discontinued use of the 3-year driving experience and fulfilled
the requirements of section 4129 while continuing to ensure that
operation of CMVs by drivers with ITDM will achieve the requisite level
of safety required of all exemptions granted under 49 U.S.C.. 31136
(e).
    Section 4129(d) also directed FMCSA to ensure that drivers of CMVs
with ITDM are not held to a higher standard than other drivers, with
the exception of limited operating, monitoring and medical requirements
that are deemed medically necessary.
    The FMCSA concluded that all of the operating, monitoring and
medical requirements set out in the September 3, 2003 notice, except as
modified, were in compliance with section 4129(d). Therefore, all of
the requirements set out in the September 3, 2003 notice, except as
modified by the notice in the Federal Register on November 8, 2005 (70
FR 67777), remain in effect.

IV. Submitting Comments

    You may submit your comments and material online or by fax, mail,
or hand delivery, but please use only one of these means. FMCSA
recommends that you include your name and a mailing address, an email
address, or a phone number in the body of your document so that FMCSA
can contact you if there are questions regarding your submission.
    To submit your comment online, go to http://www.regulations.gov and
in the search box insert the docket number FMCSA-2016-0383 and click
the search button. When the new screen appears, click on the blue
``Comment Now!'' button on the right hand side of the page. On the new
page, enter information required including the specific section of this
document to which each comment applies, and provide a reason for each
suggestion or recommendation. If you submit your comments by mail or
hand delivery, submit them in an unbound format, no larger than 8\1/2\
by 11 inches, suitable for copying and electronic filing. If you submit
comments by mail and would like to know that they reached the facility,
please enclose a stamped, self-addressed postcard or envelope.
    We will consider all comments and material received during the
comment period. FMCSA may issue a final determination at any time after
the close of the comment period.

V. Viewing Comments and Documents

    To view comments, as well as any documents mentioned in this
preamble, go to http://www.regulations.gov and in the search box insert
the docket number FMCSA-2016-0383 and click ``Search.'' Next, click
``Open Docket Folder'' and you will find all documents and comments
related to this notice.

    Issued on: February 28, 2017.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2017-04524 Filed 3-7-17; 8:45 am]
BILLING CODE 4910-EX-P